HARRY M. JANSEN KRAEMER, JR.

Corporate Board Profile

Tech Score: 0/100

DENTSPLY SIRONA Inc.

Filing Date	Source Excerpt
2019-04-12	Harry M. Jansen Kraemer, Jr., Independent, Age 64, Director since 2016, Board Committees: Governance (Chair), 2018 Director Compensation: $270,000

Option Care Health, Inc.

Filing Date	Source Excerpt
2023-04-07	Harry M. Jansen Kraemer, Jr.\nChair of the Board\nAge: 68\nDirector Since: 2019\nBoard Committees:\nAudit\nNominating and Corporate Governance (Chair)\nIndependent\nMr. Kraemer brings to the Board over 30 years of executive leadership experience, including through his service as chairman, president and chief executive officer of a large international public company, along with extensive financial expertise and significant experience with boards of directors of private and public companies, investment decisions, capital allocation activities, and complex transactions at both large companies and in private equity. Through his experience at biotechnology and pharmaceutical companies, he also brings significant expertise in the health sector and with technology and innovation.\nCareer Highlights\nExecutive Partner of Madison Dearborn Partners, a private equity firm (2005–Present)\nClinical Professor of Management and Strategy at the Kellogg School of Management at Northwestern University (2005–Present)\nChairman (2000–2004), President (1997–2004) and Chief Executive Officer (1999–2004) of Baxter International, Inc., a global, publicly-traded manufacturer of diagnostic and other health care-related products\nCertified Public Accountant\nOther Public Company Boards\nDentsply Sirona Inc. (2016–Present)\nLeidos Holdings, Inc. (1997–Present)

Filing Date

Source Excerpt

2023-04-07

Harry M. Jansen Kraemer, Jr.\nChair of the Board\nAge: 68\nDirector Since: 2019\nBoard Committees:\nAudit\nNominating and Corporate Governance (Chair)\nIndependent\nMr. Kraemer brings to the Board over 30 years of executive leadership experience, including through his service as chairman, president and chief executive officer of a large international public company, along with extensive financial expertise and significant experience with boards of directors of private and public companies, investment decisions, capital allocation activities, and complex transactions at both large companies and in private equity. Through his experience at biotechnology and pharmaceutical companies, he also brings significant expertise in the health sector and with technology and innovation.\nCareer Highlights\nExecutive Partner of Madison Dearborn Partners, a private equity firm (2005–Present)\nClinical Professor of Management and Strategy at the Kellogg School of Management at Northwestern University (2005–Present)\nChairman (2000–2004), President (1997–2004) and Chief Executive Officer (1999–2004) of Baxter International, Inc., a global, publicly-traded manufacturer of diagnostic and other health care-related products\nCertified Public Accountant\nOther Public Company Boards\nDentsply Sirona Inc. (2016–Present)\nLeidos Holdings, Inc. (1997–Present)

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22